A pilot randomized double-blind, placebo-controlled study on the effects of the topical application of pyridoxine on palmar-plantar erythrodysesthesia (PPE) induced by capecitabine or pegylated liposomal doxorubicin (PLD).

Author: AstrasGeorge, CharalambousAndreas, FilippouElena, PaikousisLefkios, TsitsiTheologia

Paper Details 
Original Abstract of the Article :
Palmar-Plantar Erythrodysesthesia (PPE) is a dose-limiting adverse event that commonly occurs with capecitabine and Pegylated Liposomal Doxorubicin-PLD treatment. The study aimed to test the effectiveness of a Pyridoxine (B6) treatment protocol in the management of PPE in patients receiving treatmen...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.ejon.2020.101866

データ提供:米国国立医学図書館(NLM)

A Pilot Study Exploring Pyridoxine for Palmar-Plantar Erythrodysesthesia

This research investigates the potential therapeutic benefits of pyridoxine (vitamin B6) in managing palmar-plantar erythrodysesthesia (PPE), a common and often debilitating side effect of certain cancer treatments. The study utilizes a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of pyridoxine in alleviating PPE symptoms in patients receiving capecitabine or pegylated liposomal doxorubicin. While the study is limited in its scope, it provides preliminary evidence suggesting that pyridoxine may hold promise as a potential treatment for PPE.

A Potential Solution for a Difficult Side Effect

The study's findings provide a glimmer of hope for patients suffering from PPE, a challenging side effect that can significantly impact their quality of life. The researchers' observation of a potential benefit of pyridoxine in managing PPE warrants further investigation. While the study is small, it opens the door to exploring this potential treatment option for patients experiencing PPE.

The Need for Further Research

The pilot study's promising results highlight the need for larger-scale, well-designed clinical trials to confirm the efficacy and safety of pyridoxine for PPE treatment. These studies should be conducted to establish a robust evidence base for pyridoxine as a potential therapeutic option for patients experiencing PPE. This research could lead to improved symptom management and potentially enhanced quality of life for cancer patients undergoing treatment.

Dr.Camel's Conclusion

This research is like finding a spring of water in the midst of a dry desert. PPE can be a challenging side effect of cancer treatment, making life difficult for patients. This study suggests that pyridoxine, like a refreshing oasis, could offer relief from the discomfort of PPE. While more research is needed, this study provides a promising starting point for finding better ways to manage this common side effect.
Date :
  1. Date Completed 2021-05-10
  2. Date Revised 2021-05-10
Further Info :

Pubmed ID

33227569

DOI: Digital Object Identifier

10.1016/j.ejon.2020.101866

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.